Search results for abx831258

Parsatuzumab, Abbexa, abx831258

Parsatuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting EGFL7, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Parsatuzumab is under investigation in clinical trial NCT01366131, Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE).